Glimigard-M2 Tablet SR
By Glimigard-M
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Astraea Life Sciences Pvt Ltd
"Astraea Court" # 9/12,GF, 5th Cross, 10th Main Road,Sree Guru Raja Lay out, Banashankari-3rd Stage,Bangalore-560085

Expires on or after
September, 2025

liver
When it comes to your liver health, it is important to exercise caution while using Glimigard-M2 Tablet SR. If you have any liver disease, it is crucial to be mindful. Your doctor may need to adjust the dose of Glimigard-M2 Tablet SR based on your liver condition. Typically, when starting this medication, a low dose is recommended for individuals with mild to moderate liver disease. However, it is not advisable to use Glimigard-M2 Tablet SR if you have severe liver disease. Be sure to consult your doctor for personalized guidance and monitoring to ensure the safe use of this medication.

kidney
Glimigard-M2 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function monitoring is advised during treatment. Consult your doctor.

alcohol
It is not safe to drink alcohol while taking Glimigard-M2 Tablet SR. Avoid alcohol while using this medication. Caution - Pregnancy

driving
Driving while taking Glimigard-M2 Tablet SR may be unsafe if your blood sugar levels are too low or too high. Do not drive if you experience these symptoms.

pregnancy
Glimigard-M2 Tablet SR may be unsafe during pregnancy. Animal studies show harmful effects on the baby. Your doctor will assess benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Glimigard-M2 Tablet SR is not safe to use while breastfeeding as it may be harmful to the baby. It is recommended to consult a doctor for suitable alternatives.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹55
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024